A61K 35/744
Lactic acid bacteria
Official title: Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
A61K35/744 (Lactic acid bacteria) appears on 2,351 US grants and 4,717 published applications in this corpus.
Search patents in A61K- Granted patents
- 2,351
- Published applications
- 4,717
- Assignees
- 1,618
- Inventors
- 7,319
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 3 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 8 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 5 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 1 | 0 |
| 1994 | 5 | 0 |
| 1995 | 8 | 0 |
| 1996 | 9 | 0 |
| 1997 | 12 | 0 |
| 1998 | 13 | 0 |
| 1999 | 13 | 0 |
| 2000 | 11 | 0 |
| 2001 | 16 | 5 |
| 2002 | 17 | 29 |
| 2003 | 17 | 39 |
| 2004 | 18 | 78 |
| 2005 | 16 | 76 |
| 2006 | 21 | 75 |
| 2007 | 27 | 70 |
| 2008 | 14 | 78 |
| 2009 | 17 | 96 |
| 2010 | 39 | 119 |
| 2011 | 47 | 127 |
| 2012 | 42 | 132 |
| 2013 | 61 | 131 |
| 2014 | 74 | 175 |
| 2015 | 73 | 189 |
| 2016 | 114 | 220 |
| 2017 | 138 | 247 |
| 2018 | 152 | 217 |
| 2019 | 140 | 279 |
| 2020 | 159 | 312 |
| 2021 | 172 | 356 |
| 2022 | 197 | 385 |
| 2023 | 196 | 362 |
| 2024 | 166 | 342 |
| 2025 | 179 | 349 |
| 2026 | 130 | 229 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Composition for preventing or treating inflammatory bowel disease6 Oct 2026US 12,751,979 B2Ajou University Industry-Academic Cooperation Foundation
- Bifidobacterium longum CCFM1206 capable of producing sulforaphane and relieving inflammation6 Oct 2026US 12,751,980 B2Jiangnan University
- Composition for improving the microbiome6 Oct 2026US 12,751,981 B2Iiaa Limited
- Oral and intestinal health products6 Oct 2026US 12,751,985 B2
- Probiotics compositions and method of using the same to enhance growth and social function in children29 Sep 2026US 12,746,262 B2The General Hospital Corporation
- Probiotic-fortified, high-protein food product and method of making same8 Oct 2026US 2026/0305659 A1
- Method of addressing alzheimer's disease or non-alzheimer's dementia8 Oct 2026US 2026/0305670 A1G. Nofar Food Agency Ltd.
- Microbiome-based GABA Cream with Chondroitin Sulfate Transdermal Delivery System8 Oct 2026US 2026/0306531 A1
- Formulation of a probiotic stable at baking temperatures and encapsulation of the same to ensure its life on shelf foods until its viability in consumption8 Oct 2026US 2026/0306559 A1Grupo Bimbo S.A. B. DE C.V.
- Treatment of cancer therapy-induced oral mucositis8 Oct 2026US 2026/0306561 A1
Most cited
By later US patents
- Synergistic bacterial compositions and methods of production and use thereof242US 9,028,841 B2Seres Health, Inc. · 2015
- Probiotic recolonisation therapy240US 8,460,648 B22013
- Compositions and methods239US 9,011,834 B1Seres Health, Inc. · 2015
- Method for treatment of idiopathic inflammatory bowel disease (IIBD)229US 5,599,795 A1997
- Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same156US 5,874,479 AWarner-Lambert Company · 1999